Katherine Crew, MD, MS, discusses treatment for patients with favorable-risk early-stage HER2-positive breast cancer.
Katherine Crew, MD, MS
Advertisement
Articles by Katherine Crew, MD, MS
Katherine Crew, MD, MS, discusses new research in the advanced HER2-positive breast cancer landscape.
Advertisement
Latest Updated Articles
Dr. Crew on New Research in Advanced HER2+ Breast CancerPublished: February 4th 2020 | Updated:
Dr. Crew on Treatment in Favorable-Risk HER2+ Breast CancerPublished: February 14th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5